PuraPharm Corporation Limited (HKG:1498)
Hong Kong · Delayed Price · Currency is HKD 0.3050
0.00 (0.00%)
Apr 2, 2026, 2:43 PM HKT
PuraPharm Corporation Revenue
In the year 2025, PuraPharm Corporation had annual revenue of 336.11M HKD, down -12.03%. PuraPharm Corporation had revenue of 163.82M in the half year ending December 31, 2025, a decrease of -22.65%.
Revenue
336.11M
Revenue Growth
-12.03%
P/S Ratio
0.49
Revenue / Employee
716.66K
Employees
469
Market Cap
163.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 336.11M | -45.98M | -12.03% |
| Dec 31, 2024 | 382.09M | -24.77M | -6.09% |
| Dec 31, 2023 | 406.86M | -41.21M | -9.20% |
| Dec 31, 2022 | 448.07M | -211.52M | -32.07% |
| Dec 31, 2021 | 659.59M | 57.78M | 9.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.08B |
| Kontafarma China Holdings | 914.71M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Qianhai Health Holdings | 677.12M |
| Tianda Pharmaceuticals | 322.95M |
| Sanai Health Industry Group Company | 104.88M |
| Extrawell Pharmaceutical Holdings | 52.65M |